Medtronic vet Montcalvo joins West Pharmaceutical Services
Montecalvo will serve as a part of the senior leadership team and oversee its global operations function, the Exton, Penn.-based company said.
A Medtronic (NYSE:MDT) vet, Montecalvo served as VP of contract manufacturing operations for Medtronic’s restorative therapies group and VP of business operations integration, overseeing Covidien’s integration with Medtronic. Montecalvo has also held senior operations and product development roles at Urologix (OCT:ULGX) and Lectec Corporation.
“David Montecalvo brings a wealth of expertise in global operations, business integration and product development,” president & CEO Eric Green said in prepared remarks. “As we continue to make significant progress in achieving the operational excellence objectives outlined in our long-term business strategy, including our margin expansion targets, we intend to leverage David’s experience to continue this progress. He shares West’s priorities of safety, quality and operational excellence and will be a valuable addition to West’s leadership team, as we work to execute our strategy to be the world leader in the integrated containment and delivery of injectable medicines.”
“I am honored to join West, and to be a part of the company’s continued success as a critical partner in the delivery of healthcare,” Montecalvo said. “There are so many exciting advancements ahead for us in the pharmaceutical, biotech and medical device industry, and I am particularly pleased to join West – a company that is at the core of helping bring innovative therapies to patients.”